- Home
- / Myriad Women’s Health
Myriad Women’s Health
Revenue
$124 M
FY, 2017
Myriad Women’s Health Summary
Company Summary
- Overview
- Myriad Women’s Health is a genetic screening and testing company. Its product offerings include hereditary cancer tests as well as carrier and prenatal screening.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2018
- HQ
- South San Francisco, CA, US | view all locations
- Cybersecurity rating
Table of Contents
Operating MetricsView all
People Screened to Date
850K
13.3%
Jan, 2018
Healthcare Professionals Served
17K
70.0%
Jan, 2018
Genetic Counseling Sessions
75K
Jan, 2018
LocationsView all
1 location detected
South San Francisco, CA HQ
United States
180 Kimball Way
Myriad Women’s Health Financials
Summary Financials
- Revenue (Q1, 2018)
- $102.6M
- Gross profit (Q1, 2018)
- $57.8M
- Net income (Q1, 2018)
- ($25.3M)
- Cash (Q1, 2018)
- $23.7M
- EBIT (Q1, 2018)
- ($17.4M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026